united therapeutics glp-1 receptor agonist Oral GLP-1-Based in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies GLP-1 Receptor Agonists: The New
Description
[DOI] [PubMed] [Google Scholar] 63.Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA
Microbial enterotypes and weight loss: results from a randomized controlled trial
Postprandial nutrient handling and gastrointestinal secretion of hormones after Roux-en-Y gastric bypass vs sleeve gastrectomy
Leone-Bay A, Grant M, Greene S, Stowell G, Daniels S, Smithson A, et al
Given the tolerability of exenatide and its direct and early effect on ICP, it may be beneficial in other conditions such as hydrocephalus, traumatic brain injury, raised ICP in stroke and meningitis and space flightassociated neuro-ocular syndrome
